Ticagrelor or Prasugrel for Platelet Inhibition in Acute Coronary Syndrome Patients
Katharina Mayer, Isabell Bernlochner(TUM Klinikum), Stefanie Schüpke, Dominick J. Angiolillo(University of Florida), Dario Bongiovanni(University Hospital Augsburg), V Karschin, Dirk Sibbing(Ludwig-Maximilians-Universität München), Heribert Schunkert(German Centre for Cardiovascular Research), Karl‐Ludwig Laugwitz(Health First), Adnan Kastrati(Deutsches Herzzentrum München)
Cited by 33
Related Papers
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
|Nature Genetics|2011|2k